William Blair Initiates Coverage of Harrow (HROW) With an Outperform Rating
Harrow, Inc. (NASDAQ:HROW) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.
Posts Tagged ‘NASDAQ:HROW’
13 Best Pharma Stocks to Buy According to Wall Street Analysts
On June 24, Jared Holz, Mizuho's healthcare strategist, appeared on CNBC's 'Fast Money' to talk about competition in the obesity drug space.
13 Stocks on Jim Cramer’s Radar Recently
On Monday's episode of Mad Money, Jim Cramer broke down the day’s market rally and argued in favor of staying invested, even in times of uncertainty.
Harrow Health, Inc. (NASDAQ:HROW) Q1 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Harrow's First Quarter 2025 Earnings Conference Call. My name is Shannon, and I will be your operator for today's call.
Harrow Health, Inc. (NASDAQ:HROW) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Harrow's Third Quarter 2024 Earnings Conference Call. My name is Michelle, and I will be your operator for today's call.
Harrow, Inc. (HROW): A Bull Case Theory
We came across a bullish thesis on Harrow, Inc. (HROW) on Simon’s Substack by Simon. In this article, we will summarize the bulls’ thesis on HROW.
Harrow Health, Inc. (NASDAQ:HROW) Q2 2024 Earnings Call Transcript
Operator: Good morning and welcome to the Harrow Second Quarter 2024 Earnings Conference Call. My name is Josh and I will be your operator for today's call.
Harrow Health, Inc. (NASDAQ:HROW) Q1 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Harrow, Inc. First Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
Harrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call Transcript
Operator: Good morning and welcome to Harrow's Fourth Quarter and Year-End 2023 Earnings Conference Call. My name is Drew, and I will be your operator for today's call.
Harrow (HROW) Fell on Lowering the Guidance
Wasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Value Strategy” fourth-quarter 2023 investor letter.
11 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the 11 best small cap pharma stocks to invest in.
Here’s How Harrow (HROW) Weighed on SRK Capital’s Performance
SRK Capital, an investment management firm, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Harrow Health, Inc. (NASDAQ:HROW) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Harrow's Third Quarter 2023 Earnings Conference Call. My name is Betsy, and I will be your operator for today's call.
Harrow Health, Inc. (NASDAQ:HROW) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Harrow's Second Quarter 2023 Earnings Conference Call. My name is Kate, and I will be your operator for today's call.
10 Best Small Cap Pharma Stocks to Buy
In this piece, we will take a look at the ten best small cap pharma stocks to buy.
Harrow Health, Inc. (NASDAQ:HROW) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Harrow's First Quarter 2023 Earnings Conference Call. My name is Joe, and I will be your operator for today's call.
Harrow Health, Inc. (NASDAQ:HROW) Q4 2022 Earnings Call Transcript
Operator: Good afternoon. And welcome to Harrow's Q4 2022 Earnings Conference Call. My name is MJ, and I will be your operator for today's call.
Is Harrow Health (HROW) an Undervalued Stock?
SRK Capital, an investment management company, recently released its fourth-quarter investor letter. A copy of the same can be downloaded here.
5 Best Low Price Pharma Stocks To Buy Now
Haleon plc (NYSE:HLN) was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Is Harrow Health (HROW) a Wise Investment Choice?
SRK Capital, an investment management firm, published its second-quarter 2022 investor letter – a copy of which can be downloaded here.
Is it a Good Choice to Invest in Harrow Health (HROW)?
SRK Capital, an investment management firm, published its fourth-quarter 2021 investor letter – a copy of which can be downloaded here.
SRK Capital: “Harrow Health (HROW) is Potentially Worth Multiples of its Current Valuation”
SRK Capital, an investment management firm, published its second quarter 2021 investor letter – a copy of which can be downloaded here.
Is HROW A Good Stock To Buy Now?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Were Hedge Funds Right About Harrow Health, Inc. (HROW)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Is Harrow Health, Inc. (HROW) A Good Stock To Buy?
Is Harrow Health, Inc. (NASDAQ:HROW) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock.
